↓ Skip to main content

Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality

Overview of attention for article published in BMC Cancer, December 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
21 Mendeley
Title
Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality
Published in
BMC Cancer, December 2013
DOI 10.1186/1471-2407-13-610
Pubmed ID
Authors

Michael Schlumpf, Claude Fischer, Diana Naehrig, Christoph Rochlitz, Martin Buess

Abstract

Randomized controlled trials have established concurrent chemo-radiotherapy as the preferred treatment option for inoperable local-regionally advanced head and neck squamous cell carcinomas (HNSCCs). Because many patients have multiple co-morbidities and would not fulfill the eligibility criteria of clinical trials, the results need to be re-evaluated in daily clinical practice with special reference to early mortality.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 5%
New Zealand 1 5%
Unknown 19 90%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 24%
Other 5 24%
Student > Ph. D. Student 3 14%
Student > Bachelor 2 10%
Student > Postgraduate 1 5%
Other 5 24%
Readers by discipline Count As %
Medicine and Dentistry 13 62%
Unspecified 4 19%
Mathematics 1 5%
Agricultural and Biological Sciences 1 5%
Chemistry 1 5%
Other 1 5%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2014.
All research outputs
#4,864,043
of 6,574,878 outputs
Outputs from BMC Cancer
#1,982
of 3,103 outputs
Outputs of similar age
#109,866
of 165,103 outputs
Outputs of similar age from BMC Cancer
#74
of 110 outputs
Altmetric has tracked 6,574,878 research outputs across all sources so far. This one is in the 14th percentile – i.e., 14% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,103 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 165,103 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.